Related Experiment Video
Updated: Jun 11, 2025

Author Spotlight: Exploring the Impact of Trauma on Cellular Aging
Published on: March 22, 2024
Causality between Telomere Length and the Risk of Hematologic Malignancies: A Bidirectional Mendelian Randomization
Guoyun Jiang1, LingXiao Cao2, Yunshan Wang1
1Department of Clinical Laboratory, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
Longer telomere length (TL) is causally linked to a higher risk of several hematologic malignancies, including leukemia and lymphoma. This finding suggests telomere maintenance could be a strategy for reducing cancer risk.
Area of Science:
- Genetics
- Oncology
- Epidemiology
Background:
- Telomere length (TL) is associated with various aspects of hematopoietic malignancies.
- Observational studies have limitations in establishing causal links between TL and hematologic malignancy risk due to confounding factors.
Purpose of the Study:
- To investigate the potential causal relationship between telomere length and the risk of developing hematologic malignancies.
- To address limitations of previous observational studies using a robust analytical approach.
Main Methods:
- A two-sample bidirectional Mendelian randomization (MR) analysis was employed.
- Genome-wide association study data for TL and hematologic malignancies were utilized.
- Inverse variance weighted, weighted median, and MR-Egger methods were applied for robust causal inference.
Main Results:
- Longer TL was significantly associated with an increased risk of acute lymphocytic leukemia, chronic lymphocytic leukemia, multiple myeloma, Hodgkin lymphoma, and non-Hodgkin lymphoma.
- Reverse MR analysis confirmed that hematologic malignancies do not influence TL.
- Sensitivity analyses indicated the robustness of the findings and absence of significant pleiotropy.
Conclusions:
- This MR study provides strong evidence for a causal association between longer telomere length and an increased risk of specific hematologic malignancies.
- Telomere length may serve as a potential biomarker for risk stratification and management of hematologic cancers.
- Targeting telomere maintenance pathways could represent a novel strategy for hematologic malignancy prevention.
Related Concept Videos
Replicative Cell Senescence
Telomeres and Telomerase
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Non-LTR Retrotransposons
Cancers Originate from Somatic Mutations in a Single Cell
Replication in Eukaryotes
Many Proteins Orchestrate Replication at the Origin
Eukaryotic replication follows many of the same...

